Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Delta 9 Cannabis Inc DLTNF

Delta 9 Cannabis Inc. is a Canada-based vertically integrated cannabis company. The Company operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. It also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. It is focused on producing and selling cannabis oils, extracts, and derivative products.


GREY:DLTNF - Post by User

Post by golfyetion Jan 12, 2021 11:47am
157 Views
Post# 32276164

No Respect for DN

No Respect for DN

New Brunswick based Organigram announced this quarter $19M in revs with a $0.17/sh LOSS vs analyst expectations of a $0.04/sh loss.   Quarterly revenues on a steady decline over the last year -- CEO says they have ZERO ideas or plans on how to penetrate US market.

We are on the cusp of similar revenues and have positive EBIDTA .  Their market cap however remains TEN TIMES higher than ours....

OGI has 9 Analysts and DN has ZERO!

This points to a clear failure of DN management to attract broad investor attention and interest in DN while they happily dilute us at about ten times the rate that they should, when you consider where our market cap SHOULD BE right now, as in TEN TIMES HIGHER!!  WTF!!

I'm not sure how much longer I am going to tolerate this ans sit on the dock when POS competitors get ten times the respect and market cap DN gets.

<< Previous
Bullboard Posts
Next >>